Bayesian Capital Management, LP Insulet Corp Transaction History

Bayesian Capital Management, LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$161.02 - $206.98 $531,366 - $683,034	3,300 New	3,300 $665,000
Q2 2023 Aug 14, 2023	SELL	$272.48 - $330.23 $2.95 Million - $3.58 Million	-10,832 Reduced 89.05%	1,332 $384,000
Q1 2023 May 15, 2023	BUY	$276.36 - $326.03 $2.1 Million - $2.48 Million	7,600 Added 166.52%	12,164 $3.88 Million
Q4 2022 Feb 14, 2023	BUY	$212.22 - $313.46 $968,572 - $1.43 Million	4,564 New	4,564 $1.34 Million
Q2 2020 Aug 14, 2020	SELL	$159.17 - $224.73 $332,665 - $469,685	-2,090 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$130.01 - $216.44 $2.15 Million - $3.58 Million	-16,523 Reduced 88.77%	2,090 $346,000
Q4 2019 Feb 14, 2020	BUY	$144.81 - $186.0 $1.59 Million - $2.05 Million	11,000 Added 144.49%	18,613 $3.19 Million
Q3 2019 Nov 13, 2019	BUY	$117.35 - $167.95 $547,907 - $784,158	4,669 Added 158.59%	7,613 $1.26 Million
Q2 2019 Aug 13, 2019	BUY	$82.13 - $120.73 $241,790 - $355,429	2,944 New	2,944 $351,000
Q3 2018 Nov 14, 2018	SELL	$81.43 - $108.13 $368,959 - $489,937	-4,531 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$83.27 - $101.93 $377,296 - $461,844	4,531 New	4,531 $388,000
Q1 2018 May 15, 2018	SELL	$68.49 - $87.2 $890,369 - $1.13 Million	-13,000 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$55.67 - $71.8 $211,546 - $272,840	3,800 Added 41.3%	13,000 $897,000
Q3 2017 Nov 14, 2017	BUY	$49.68 - $59.46 $457,056 - $547,032	9,200	9,200 $507,000

687

62.7M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.7B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.